Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
J Biochem Mol Toxicol ; 37(7): e23361, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-36999444

RESUMEN

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by immune abnormalities leading to multi-organ damage. The activation of autoreactive B cell differentiation will lead to the production of pathogenic autoantibodies, contributing to the development of SLE. However, the effects of Ophiopogonin D (OP-D) on B cell activation and autoantibody production as well as renal injury in the pathogenesis of SLE remain unclear. MRL/lpr mice, one of the most commonly used animal models of SLE, were intragastrically administered with 5 mg/kg/d OP-D at 17 weeks of age for 3 weeks. The survival rates of mice in each group were monitored for 6 weeks until 23 weeks of age. Proteinuria and serum creatinine levels were measured. Serum levels of immunoglobulin (Ig)G, IgM, and anti-dsDNA autoantibodies were detected by enzyme-linked immunosorbent assay. Numbers of CD19+ B cells in the blood, spleen and bone marrow and numbers of splenic germinal center (GC) B cells were calculated by using flow cytometry. OP-D treatment prolonged survival in MRL/lpr mice. OP-D treatment reduced proteinuria and serum creatinine levels as well as mitigated renal pathological alternation in MRL/lpr mice. Furthermore, serum levels of IgG, IgM, and anti-dsDNA autoantibodies were reduced by OP-D treatment. OP-D lessened not only CD19+ B cells in the spleen and bone marrow but also plasma cells that secreted anti-dsDNA autoantibodies, IgG and IgM in the spleen and bone marrow. OP-D ameliorated the progression of SLE by inhibiting the secretion of autoantibodies though reducing B cell numbers.


Asunto(s)
Lupus Eritematoso Sistémico , Ratones , Animales , Creatinina , Ratones Endogámicos MRL lpr , Lupus Eritematoso Sistémico/tratamiento farmacológico , Lupus Eritematoso Sistémico/patología , Autoanticuerpos , Proteinuria , Inmunoglobulina G , Inmunoglobulina M , Recuento de Células , Modelos Animales de Enfermedad
2.
Molecules ; 16(8): 6243-54, 2011 Jul 25.
Artículo en Inglés | MEDLINE | ID: mdl-21788932

RESUMEN

In this work, the anticancer activity of chamaejasmine was studied by evaluating its in vitro cytotoxicity against several human cancer cell lines (MCF-7, A549, SGC-7901, HCT-8, HO-4980, Hela, HepG2, PC-3, LNCap, Vero and MDCK) using the MTT assay. Results indicated chamaejasmine showed more notable anticancer activity than taxol against PC-3 cells, with IC50 values of 2.28 and 3.98 µM, respectively. Furthermore, Western blot analysis showed that chamaejasmine was able to increase the expression of ß-tubulin, but not α-tubulin. In silico simulations indicated that chamaejasmine specifically interacts with the active site which is located at the top of ß-tubulin, thanks to the presence of strong hydrophobic effects between the core templates and the hydrophobic surface of the TB active site. The binding energy (E(inter)) was calculated to be -164.77 kcal·mol⁻¹. Results presented here suggest that chamaejasmine possesses anti-cancer properties relating to ß-tubulin depolymerization inhibition, and therefore is a potential source of anticancer leads for the pharmaceutical industry.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Biflavonoides/farmacología , Supervivencia Celular/efectos de los fármacos , Neoplasias/tratamiento farmacológico , Tubulina (Proteína)/biosíntesis , Animales , Antineoplásicos Fitogénicos/uso terapéutico , Biflavonoides/uso terapéutico , Western Blotting , Línea Celular Tumoral , Chlorocebus aethiops , Perros , Femenino , Humanos , Concentración 50 Inhibidora , Modelos Moleculares , Neoplasias/patología , Paclitaxel/farmacología , Unión Proteica , Termodinámica , Tubulina (Proteína)/química , Tubulina (Proteína)/metabolismo , Células Vero
3.
J Theor Biol ; 267(3): 363-74, 2010 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-20831875

RESUMEN

Docking and molecular dynamics were used to study the nine ligands (see Scheme 1) at the neuraminidase (NA) active sites. Their binding modes are structurally and energetically different, with details given in the text. Compared with 1A (oseltamivir carboxylate), the changes of core template or/and functional groups in the other ligands cause the reductions of interaction energies and numbers of H-bonds with the NA proteins. Nonetheless, all these ligands occupy the proximity space at the NA active sites and share some commonness in their binding modes. The fragment approach was then used to analyze and understand the binding specificities of the nine ligands. The contributions of each core template and functional group were evaluated. It was found that the core templates rather than functional groups play a larger role during the binding processes; in addition, the binding qualities are determined by the synergistic effects of the core templates and functional groups. Among the nine ligands, 1A (oseltamivir carboxylate) has the largest synergistic energy and its functional groups fit perfectly with the NA active site, consistent with the largest interaction energy, numerous H-bonds with the NA active-site residues as well as experimentally lowest IC(50) value. Owing to the poorer metabolizability than oseltamivir, large contribution of the benzene core template and fine synergistic effects of the functional groups, the 4-(N-acetylamino)-5-guanidino-3-(3-pentyloxy)benzoic acid should be an ideal lead compound for optimizing NA drugs.


Asunto(s)
Diseño de Fármacos , Modelos Moleculares , Simulación de Dinámica Molecular , Neuraminidasa/antagonistas & inhibidores , Neuraminidasa/química , Ácidos Carbocíclicos , Benzoatos/química , Benzoatos/farmacología , Dominio Catalítico , Ciclohexenos/química , Ciclohexenos/farmacología , Ciclopentanos/química , Ciclopentanos/farmacología , Guanidinas/química , Guanidinas/farmacología , Humanos , Enlace de Hidrógeno , Gripe Humana/tratamiento farmacológico , Concentración 50 Inhibidora , Ligandos , Estructura Molecular , Orthomyxoviridae/efectos de los fármacos , Oseltamivir/análogos & derivados , Oseltamivir/química , Oseltamivir/farmacología , Unión Proteica , Electricidad Estática , Relación Estructura-Actividad , Termodinámica
4.
J Sep Sci ; 32(2): 192-201, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19107767

RESUMEN

A method based on microwave-assisted extraction (MAE) has been developed for the determination of paclitaxel and five related taxoids, namely 10-deacetylbaccatin III (10-DAB III), cephalomannine, 10-deacetylpaclitaxel (10-DAT), 7-xyl-10- deacetylpaclitaxel (7-xyl-10-DAT), and 7-epi-10-deacetylpaclitaxel (7-epi-10-DAT) in Taxus species in this study. The influential parameters of the MAE procedure were optimized, and the optimal conditions were as follows: extraction solvent 80% ethanol solution, solid/liquid ratio 1:10 (g/mL), temperature 50 degrees C, and three extraction cycles, each cycle 10 min. The method validation for LC-MS/MS analysis was performed. The LOD and LOQ were 3.16-9.20 and 12.20-30.45 ng/mL, respectively. Repeatability and reproducibility for the six taxiods with RSD ranged from 2.78 to 3.85% and from 5.26 to 6.60%. The recoveries of the method for the six taxoids were 92.6-105.6%. The developed MAE-LC-MS/MS method was also successfully applied to determine the contents of six taxoids in different Taxus species.


Asunto(s)
Cromatografía Liquida/métodos , Microondas , Espectrometría de Masas en Tándem/métodos , Taxoides/análisis , Taxoides/química , Taxus/química , Estructura Molecular , Solventes , Temperatura , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda